4th Quarter - Report
KOUNTOUPES DENHAM CARR & REID, LLC for GLENMARK PHARMACEUTICALS, INC., USA
Income
$50,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to tax reform.
Foreign entity interest: Glenmark
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID PAUL PELUSO | — |
| MARY R "RANDI" REID | — |
Health Issues HCR
General education about the generic pharmaceutical industry.
Foreign entity interest: Glenmark
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| MARY R "RANDI" REID | — |
| ROSE SULLIVAN (LISTED IN ERROR) | — |
Medicare/Medicaid MMM
Issues related to Medicaid CPI Penalty.
Foreign entity interest: Glenmark
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
Pharmacy PHA
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals.
Foreign entity interest: Glenmark
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| MARY R "RANDI" REID | — |
| ROSE SULLIVAN (LISTED IN ERROR) | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.